申请人:Fairhurst Robin Alec
公开号:US20100298286A1
公开(公告)日:2010-11-25
The present invention relates to a compound of formula I
and its salts, wherein the substituents are as defined in the description, to compositions and use of the compounds in the treatment of diseases ameliorated by inhibition of phosphatidylinositol 3-kinase.
本发明涉及公式I及其盐的化合物,其中取代基如描述中所定义,以及所述化合物在治疗通过抑制磷脂酰肌醇3-激酶改善的疾病中的组合物和用途。